Advert - Novo Nordisk – Case AUTH/3821/9/23

For inappropriate sponsorship arrangements that amounted to an inducement and a failure to disclose transfers of value Novo Nordisk was ruled in breach of the following clauses of the 2021 and 2019 Codes:

2021 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 28.1 - Failing to document and publicly disclose certain transfers of value

2019 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards